M&A Deal Summary

Hony Capital Acquires Simcere Pharmaceutical

On August 28, 2013, private equity firm Hony Capital acquired life science company Simcere Pharmaceutical

Acquisition Highlights
  • This is Hony Capital’s 3rd transaction in the Life Science sector.
  • This is Hony Capital’s 19th transaction in China.
Investment Fate
  • Simcere Pharmaceutical went public in 2020.

M&A Deal Summary

Date 2013-08-28
Target Simcere Pharmaceutical
Sector Life Science
Buyer(s) Hony Capital
Deal Type Going Private

Target

Simcere Pharmaceutical

Nanjing, China
Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug Endu in the rapidly growing China market. The company currently manufactures and sells more than 50 pharmaceutical products and is the exclusive distributor of three additional pharmaceutical products marketed under its own brand name. Simcere Pharmaceutical was founded in 1995 and is based in Nanjing, China.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Hony Capital

Beijing, China

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2003
PE ASSETS 13.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Hony Capital (Beijing) Co., Ltd. is a private equity firm focused on investment opportunities across China. The Firm targets buyouts and commercializations of Chinese state-owned enterprises as well as growth capital investments in rapidly-growing private Chinese companies. Hony's primary focus is within the construction materials, pharmaceuticals, construction machinery, retail, and consumer goods sectors, however, the firm will also consider opportunities in media/entertainment, financial services, energy, and resources. Hony is a long-term investor and is sponsored by Legend Holdings, parent of computer maker Lenovo amongst other properties. Hony Capital is located in Beijing, China.


DEAL STATS #
Overall 22 of 41
Sector: Life Science M&A 3 of 4
Type: Going Private M&A Deals 1 of 1
Country: China M&A 19 of 31
Year: 2013 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-01 CIFA

Milano, Italy

​CIFA is a concrete equipment manufacturer offering full-line concrete equipment including concrete pumps, concrete mixers, plants, and formworks. CIFA was founded in 1928 and is based in Milano, Italy.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-12 PizzaExpress

Middlesex, United Kingdom

Pizza Express operates 436 restaurants in the UK along with 68 internationally, including 22 in China. PizzaExpress was founded in 1965 and is based in Middlesex, United Kingdom.

Buy £900M